Photo Release -- Andrei Isaev Congratulates Russia on Winning the Winter Olympic Games 2014!
25 févr. 2014 17h07 HE
|
KVINTESS F&DI Holdings Corp.
TAMPA, Fla., Feb. 25, 2014 (GLOBE NEWSWIRE) -- "The final medal count for Russia was 33 total. 13 were gold, 11 silver and 9 were bronze, an Olympic high for the nation of Russia. I am very proud of...
KVINTESS F&DI Met With Ambassador of Ukraine
24 févr. 2014 12h04 HE
|
KVINTESS F&DI Holdings Corp.
BAKU, Azerbaijan, Feb. 24, 2014 (GLOBE NEWSWIRE) -- Last week the representative of the KVINTESS F&DI Holdings Corp., Mr. Dmitry Zarechny (Director of the CIS development department), met with the...
Photo Release -- KVINTESS F&DI HOLDINGS CORP Welcomes Tim Raines as a New Shareholder
21 févr. 2014 14h47 HE
|
KVINTESS F&DI Holdings Corp.
TAMPA, Fla., Feb. 21, 2014 (GLOBE NEWSWIRE) -- The Company is pleased to welcome Tim Raines, an American baseball legend and nominee for honorary membership in the Baseball Hall of Fame in the United...
Revance Therapeutics, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Over-Allotment Option
11 févr. 2014 16h05 HE
|
Revance Therapeutics, Inc
NEWARK, Calif., Feb. 11, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), a biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic...
Biocept, Inc. Announces Closing of Initial Public Offering
10 févr. 2014 18h06 HE
|
Biocept, Inc.
SAN DIEGO, Feb. 10, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), an oncology diagnostics company focused on improving individual patient treatment, announced today the closing of its...
Oculus Innovative Sciences Announces Completion of Agreements Required for IPO by Company's Subsidiary, Ruthigen, Inc.
06 févr. 2014 16h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that as of January 31, 2014, Oculus has entered into certain new and amended...
Cara Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Over-Allotment Option
05 févr. 2014 16h01 HE
|
Cara Therapeutics, Inc.
SHELTON, Conn., Feb. 5, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Biocept, Inc. Announces Pricing of Initial Public Offering
04 févr. 2014 18h19 HE
|
Biocept, Inc.
SAN DIEGO, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc., an oncology diagnostics company focused on improving individual patient treatment, today announced the pricing of its initial public offering...
Ultragenyx Announces Pricing of Initial Public Offering
30 janv. 2014 21h00 HE
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., Jan. 30, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today...
Inogen Files Registration Statement With SEC for an Initial Public Offering
27 nov. 2013 18h02 HE
|
Inogen
GOLETA, Calif., Nov. 27, 2013 (GLOBE NEWSWIRE) -- Inogen, Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public...